Jan Erik Varhaug

5.5k citations
96 papers · 4.4k indexed · 1 hit paper · h-index 35
Topics
Peptidase Inhibition and Analysis (16 papers)Ubiquitin and proteasome pathways (15 papers)Thyroid Cancer Diagnosis and Treatment (15 papers)

In The Last Decade

Jan Erik Varhaug

96 papers receiving 4.3k citations

Hit Papers

Specific P53 mutations are associated with de novo resist...19962026200620161996200400600

Peers

Jan Erik Varhaug
Comparison fields: 5 of 126
  • Oncology 2.2k
  • Molecular Biology 2.2k
  • Endocrinology, Diabetes and Metabolism 890
  • Cancer Research 850
  • Genetics 547
Replace Isabelle Dusanter‐Fourt with:
Isabelle Dusanter‐Fourt France
Mona F. Melhem United States
Olle Larsson Sweden
David W. Dawson United States
Jakob Dupont United States
W. Böcker Germany
Pnina Brodt Canada
Stefano Pepe Italy
Natalia S. Pellegata Germany
Hideyuki Yoshitomi Japan
Jan Erik Varhaug relative to Isabelle Dusanter‐Fourt France Isabelle Dusanter‐Fourt's profile →
Citations per field
00.5×1.5×2.3×
Isabelle Dusanter‐Fourt · 1×
Citations per year

Countries citing papers authored by Jan Erik Varhaug

Since Specialization
Citations

This map shows the geographic impact of Jan Erik Varhaug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Erik Varhaug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Erik Varhaug more than expected).

Fields of papers citing papers by Jan Erik Varhaug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Erik Varhaug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Erik Varhaug. The network helps show where Jan Erik Varhaug may publish in the future.

Co-authorship network of co-authors of Jan Erik Varhaug

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Erik Varhaug. A scholar is included among the top collaborators of Jan Erik Varhaug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Erik Varhaug. Jan Erik Varhaug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 32
2 13
3 48
4 33
5 39
6 16
7 15
8 4
9 35
10 11
11
Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.
64
12 3
13 39
14 12
15 15
16 12
17 12
18 3
19 3
20 1

About Jan Erik Varhaug

Jan Erik Varhaug is a scholar working on Oncology, Gastroenterology and Cancer Research, having authored 96 papers that have together received 4.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (16 papers), Ubiquitin and proteasome pathways (15 papers) and Thyroid Cancer Diagnosis and Treatment (15 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (850 citations) and Endocrinology, Diabetes and Metabolism (890 citations). Jan Erik Varhaug has collaborated with scholars based in Norway, United States and Netherlands. Frequent co-authors include Johan R. Lillehaug, Lars A. Akslen, Thomas Arnesen, Turid Aas, Per Eystein Lønning, Stephanie Geisler, Hilde Johnsen, Anne‐Lise Børresen, Darina Gromyko and Birgitte Smith‐Sørensen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026